Spironolactone Tablet, Film Coated
Product Images NDC 63629-2438

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 63629-2438). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

FDA Label Image

Figure01 (Fig01)

This text describes the statistical significance of Spironolactone compared to a placebo over a period of two months. The Logerankp value is less than 0.001, indicating a strong difference between the effectiveness of the two treatments. The number 82 is possibly a value related to the Spironolactone treatment, while n=841 indicates the sample size of the placebo group.*

FDA Label Image

Figure02 (Fig02)

FDA Label Image

Label (Lbl636292438)

This is a description for a medication named "Spironolactone Tablets, USP" with NDC number 63629-2438-1 manufactured by NILD Pharmaceuticals. It comes in the form of film-coated tablets with 50 mg Spironolactone. The medication should be kept out of reach of children and stored between 20° to 25°C (68° to 77°F). It should also be dispensed in a tightly sealed container with a child-resistant closure. Further information regarding the medication is not available.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.